Specialty Generics - Global Market Outlook (2016-2022)                 

January 2017 | 170 pages | ID: SF7A9CB558CEN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Specialty Generics market is estimated at $XX billion in 2016 and is expected to reach $XX billion by 2022 growing at a CAGR of XX% from 2016 to 2022. Increase in prevalence of cancer across the globe and favourable government policies are the factors fuelling the market growth. Whereas factors like lack of skilled professionals is restraining the market. Oncology segment is anticipated to grow at higher CAGR during forecast period owing to the expirations of existing patent. North America accounted for the highest market share as compared to other regions owing to favourable government policies. Asia pacific region is expected to show healthy growth rate during forecast period.

Some of the key players in the market include Valeant Pharmaceuticals International, Inc., Novartis, Pfizer Inc., Turing Pharmaceuticals, Teva Pharmaceutical Ltd., Mylan N.V., Akorn, Inc., Mallinckrodt, Intellipharmaceutics and Alvogen.

Route of Administration Covered:

• Topical
• Parenteral
• Oral
• Other Route of Administration

Disease Indications Covered:

• Multiple Sclerosis
• Infectious diseases
• Oncology
• Other Disease Indications

Distribution Channels Covered:

• Mail Order Pharmacies
• Hospital Pharmacies
• Retail Pharmacies

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• Italy
• UK
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia Pacific
• Rest of the World
• Middle East
• Brazil
• Argentina
• South Africa
• Egypt

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Futuristic Market Scenario

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL SPECIALTY GENERICS MARKET, BY ROUTE OF ADMINISTRATION

5.1 Introduction
5.2 Topical
5.3 Parenteral
5.4 Oral
5.5 Other Route of Administration

6 GLOBAL SPECIALTY GENERICS MARKET, BY DISEASE INDICATION

6.1 Introduction
6.2 Multiple Sclerosis
6.3 Infectious diseases
6.4 Oncology
6.5 Other Disease Indications

7 GLOBAL SPECIALTY GENERICS MARKET, BY DISTRIBUTION CHANNEL

7.1 Introduction
7.2 Mail Order Pharmacies
7.3 Hospital Pharmacies
7.4 Retail Pharmacies

8 GLOBAL SPECIALTY GENERICS MARKET, BY GEOGRAPHY

8.1 North America
  8.1.1 US
  8.1.2 Canada
  8.1.3 Mexico
8.2 Europe
  8.2.1 Germany
  8.2.2 France
  8.2.3 Italy
  8.2.4 UK
  8.2.5 Spain
  8.2.6 Rest of Europe
8.3 Asia Pacific
  8.3.1 Japan
  8.3.2 China
  8.3.3 India
  8.3.4 Australia
  8.3.5 New Zealand
  8.3.6 Rest of Asia Pacific
8.4 Rest of the World
  8.4.1 Middle East
  8.4.2 Brazil
  8.4.3 Argentina
  8.4.4 South Africa
  8.4.5 Egypt

9 KEY DEVELOPMENTS

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 COMPANY PROFILING

10.1 Valeant Pharmaceuticals International, Inc.
10.2 Novartis
10.3 Pfizer Inc.
10.4 Turing Pharmaceuticals
10.5 Teva Pharmaceutical Ltd.
10.6 Mylan N.V.
10.7 Akorn, Inc.
10.8 Mallinckrodt
10.9 Intellipharmaceutics
10.10 Alvogen

List Of Tables

LIST OF TABLES

Table 1 Global Specialty Generics Market Outlook, By Region (2014-2022) ($MN)
Table 2 Global Specialty Generics Market Outlook, By Route of Administration (2014-2022) ($MN)
Table 3 Global Specialty Generics Market Outlook, By Topical (2014-2022) ($MN)
Table 4 Global Specialty Generics Market Outlook, By Parenteral (2014-2022) ($MN)
Table 5 Global Specialty Generics Market Outlook, By Oral (2014-2022) ($MN)
Table 6 Global Specialty Generics Market Outlook, By Other Route of Administration (2014-2022) ($MN)
Table 7 Global Specialty Generics Market Outlook, By Disease Indication (2014-2022) ($MN)
Table 8 Global Specialty Generics Market Outlook, By Multiple Sclerosis (2014-2022) ($MN)
Table 9 Global Specialty Generics Market Outlook, By Infectious diseases (2014-2022) ($MN)
Table 10 Global Specialty Generics Market Outlook, By Oncology (2014-2022) ($MN)
Table 11 Global Specialty Generics Market Outlook, By Other Disease Indications (2014-2022) ($MN)
Table 12 Global Specialty Generics Market Outlook, By Distribution Channel (2014-2022) ($MN)
Table 13 Global Specialty Generics Market Outlook, By Mail Order Pharmacies (2014-2022) ($MN)
Table 14 Global Specialty Generics Market Outlook, By Hospital Pharmacies (2014-2022) ($MN)
Table 15 Global Specialty Generics Market Outlook, By Retail Pharmacies (2014-2022) ($MN)
Table 16 North America Specialty Generics Market Outlook, By Country (2014-2022) ($MN)
Table 17 North America Specialty Generics Market Outlook, By Route of Administration (2014-2022) ($MN)
Table 18 North America Specialty Generics Market Outlook, By Topical (2014-2022) ($MN)
Table 19 North America Specialty Generics Market Outlook, By Parenteral (2014-2022) ($MN)
Table 20 North America Specialty Generics Market Outlook, By Oral (2014-2022) ($MN)
Table 21 North America Specialty Generics Market Outlook, By Other Route of Administration (2014-2022) ($MN)
Table 22 North America Specialty Generics Market Outlook, By Disease Indication (2014-2022) ($MN)
Table 23 North America Specialty Generics Market Outlook, By Multiple Sclerosis (2014-2022) ($MN)
Table 24 North America Specialty Generics Market Outlook, By Infectious diseases (2014-2022) ($MN)
Table 25 North America Specialty Generics Market Outlook, By Oncology (2014-2022) ($MN)
Table 26 North America Specialty Generics Market Outlook, By Other Disease Indications (2014-2022) ($MN)
Table 27 North America Specialty Generics Market Outlook, By Distribution Channel (2014-2022) ($MN)
Table 28 North America Specialty Generics Market Outlook, By Mail Order Pharmacies (2014-2022) ($MN)
Table 29 North America Specialty Generics Market Outlook, By Hospital Pharmacies (2014-2022) ($MN)
Table 30 North America Specialty Generics Market Outlook, By Retail Pharmacies (2014-2022) ($MN)
Table 31 Europe Specialty Generics Market Outlook, By Country (2014-2022) ($MN)
Table 32 Europe Specialty Generics Market Outlook, By Route of Administration (2014-2022) ($MN)
Table 33 Europe Specialty Generics Market Outlook, By Topical (2014-2022) ($MN)
Table 34 Europe Specialty Generics Market Outlook, By Parenteral (2014-2022) ($MN)
Table 35 Europe Specialty Generics Market Outlook, By Oral (2014-2022) ($MN)
Table 36 Europe Specialty Generics Market Outlook, By Other Route of Administration (2014-2022) ($MN)
Table 37 Europe Specialty Generics Market Outlook, By Disease Indication (2014-2022) ($MN)
Table 38 Europe Specialty Generics Market Outlook, By Multiple Sclerosis (2014-2022) ($MN)
Table 39 Europe Specialty Generics Market Outlook, By Infectious diseases (2014-2022) ($MN)
Table 40 Europe Specialty Generics Market Outlook, By Oncology (2014-2022) ($MN)
Table 41 Europe Specialty Generics Market Outlook, By Other Disease Indications (2014-2022) ($MN)
Table 42 Europe Specialty Generics Market Outlook, By Distribution Channel (2014-2022) ($MN)
Table 43 Europe Specialty Generics Market Outlook, By Mail Order Pharmacies (2014-2022) ($MN)
Table 44 Europe Specialty Generics Market Outlook, By Hospital Pharmacies (2014-2022) ($MN)
Table 45 Europe Specialty Generics Market Outlook, By Retail Pharmacies (2014-2022) ($MN)
Table 46 Asia Pacific Specialty Generics Market Outlook, By Country (2014-2022) ($MN)
Table 47 Asia Pacific Specialty Generics Market Outlook, By Route of Administration (2014-2022) ($MN)
Table 48 Asia Pacific Specialty Generics Market Outlook, By Topical (2014-2022) ($MN)
Table 49 Asia Pacific Specialty Generics Market Outlook, By Parenteral (2014-2022) ($MN)
Table 50 Asia Pacific Specialty Generics Market Outlook, By Oral (2014-2022) ($MN)
Table 51 Asia Pacific Specialty Generics Market Outlook, By Other Route of Administration (2014-2022) ($MN)
Table 52 Asia Pacific Specialty Generics Market Outlook, By Disease Indication (2014-2022) ($MN)
Table 53 Asia Pacific Specialty Generics Market Outlook, By Multiple Sclerosis (2014-2022) ($MN)
Table 54 Asia Pacific Specialty Generics Market Outlook, By Infectious diseases (2014-2022) ($MN)
Table 55 Asia Pacific Specialty Generics Market Outlook, By Oncology (2014-2022) ($MN)
Table 56 Asia Pacific Specialty Generics Market Outlook, By Other Disease Indications (2014-2022) ($MN)
Table 57 Asia Pacific Specialty Generics Market Outlook, By Distribution Channel (2014-2022) ($MN)
Table 58 Asia Pacific Specialty Generics Market Outlook, By Mail Order Pharmacies (2014-2022) ($MN)
Table 59 Asia Pacific Specialty Generics Market Outlook, By Hospital Pharmacies (2014-2022) ($MN)
Table 60 Asia Pacific Specialty Generics Market Outlook, By Retail Pharmacies (2014-2022) ($MN)
Table 61 RoW Specialty Generics Market Outlook, By Country (2014-2022) ($MN)
Table 62 RoW Specialty Generics Market Outlook, By Route of Administration (2014-2022) ($MN)
Table 63 RoW Specialty Generics Market Outlook, By Topical (2014-2022) ($MN)
Table 64 RoW Specialty Generics Market Outlook, By Parenteral (2014-2022) ($MN)
Table 65 RoW Specialty Generics Market Outlook, By Oral (2014-2022) ($MN)
Table 66 RoW Specialty Generics Market Outlook, By Other Route of Administration (2014-2022) ($MN)
Table 67 RoW Specialty Generics Market Outlook, By Disease Indication (2014-2022) ($MN)
Table 68 RoW Specialty Generics Market Outlook, By Multiple Sclerosis (2014-2022) ($MN)
Table 69 RoW Specialty Generics Market Outlook, By Infectious diseases (2014-2022) ($MN)
Table 70 RoW Specialty Generics Market Outlook, By Oncology (2014-2022) ($MN)
Table 71 RoW Specialty Generics Market Outlook, By Other Disease Indications (2014-2022) ($MN)
Table 72 RoW Specialty Generics Market Outlook, By Distribution Channel (2014-2022) ($MN)
Table 73 RoW Specialty Generics Market Outlook, By Mail Order Pharmacies (2014-2022) ($MN)
Table 74 RoW Specialty Generics Market Outlook, By Hospital Pharmacies (2014-2022) ($MN)
Table 75 RoW Specialty Generics Market Outlook, By Retail Pharmacies (2014-2022) ($MN)